Sonoma Pharmaceuticals SNOA
NASDAQ SNOA
$1.25 -0.03 (-2.34%)
At close: Oct 1, 2026 · 4:00 PM EDT

Sonoma Pharmaceuticals (SNOA) Research & Development (2010 - 2026)

Updated

Sonoma Pharmaceuticals' Research & Development was $597,000 in fiscal Q1 2027 (quarter ended Jun 30, 2026), up 0.5% from $594,000 a year earlier and up 9.5% from the prior quarter.

Analysis

Sonoma Pharmaceuticals (SNOA) Research & Development (2010 - 2026) Analysis & Trends

On a trailing twelve-month basis, Sonoma Pharmaceuticals' Research & Development was $2.27 million through Jun 30, 2026, up 17.3% year-over-year; for FY2026 (ended Mar 31, 2026), it was $2.27 million, up 25.2% from FY2025.

  • Research & Development shows a five-year compound annual growth rate of 32.6% (FY2021 to FY2026).
  • In earlier fiscal years, Research & Development was $1.81 million in FY2025 (-3.0%), $1.87 million in FY2024 (+803.9%), $207,000 in FY2023 (+65.6%) and $125,000 in FY2022 (-77.5%).
  • The fiscal Q1 2027 figure marks the highest quarterly Research & Development since fiscal Q3 2024.
  • Compared with a year earlier, Research & Development has increased for six straight quarters, with growth averaging 8.7% over the last eight quarters.
  • The best year-over-year quarter for Research & Development over five years was fiscal Q2 2024 (growth of 168.0%); the worst was fiscal Q4 2022 (a decline of 96.9%).
  • Per Business Quant data, SNOA's Research & Development in the three fiscal quarters before Q1 2027 was $545,000 (Q4 2026), $557,000 (Q3 2026) and $575,000 (Q2 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Thermo Fisher Scientific 249.71 Bn 228.86 Bn 4.88 Bn 364.00 Mn
2 Abbott Laboratories 171.00 Bn 142.08 Bn 7.27 Bn 892.00 Mn
3 Danaher 155.79 Bn 139.61 Bn 3.61 Bn 412.00 Mn
4 Intuitive Surgical 143.91 Bn 123.46 Bn 1.96 Bn 370.60 Mn
5 Medtronic 110.42 Bn 76.29 Bn 6.34 Bn 771.00 Mn
6 Stryker 105.71 Bn 91.82 Bn 4.50 Bn 434.00 Mn
7 Boston Scientific 63.26 Bn 58.27 Bn 3.85 Bn 554.00 Mn
8 Edwards Lifesciences 49.80 Bn 33.91 Bn 1.35 Bn 278.90 Mn
9 Becton Dickinson 48.78 Bn 45.93 Bn 2.32 Bn 258.00 Mn
10 Sonoma Pharmaceuticals 4.92 Mn -8.41 Mn 2.58 Mn 597,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 597,000.00
Mar 31, 2026 545,000.00
Dec 31, 2025 557,000.00
Sep 30, 2025 575,000.00
Jun 30, 2025 594,000.00
Mar 31, 2025 411,000.00
Dec 31, 2024 427,000.00
Sep 30, 2024 506,000.00
Jun 30, 2024 470,000.00
Mar 31, 2024 409,000.00
Dec 31, 2023 601,000.00
Sep 30, 2023 536,000.00
Jun 30, 2023 325,000.00
Mar 31, 2023 201,000.00
Sep 30, 2022 200,000.00
Jun 30, 2022 206,000.00
Mar 31, 2022 4,000.00
Dec 31, 2021 26,000.00
Sep 30, 2021 10,000.00
Jun 30, 2021 84,000.00
API Access

Sonoma Pharmaceuticals Research & Development API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=research-and-development&ticker=SNOA&period=max&api_key=YOUR_API_KEY